Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Intec Parent's Enterprise Value is $17.75 Mil.
Intec Parent's EBIT for the trailing twelve months (TTM) ended in Mar. 2021 was $-14.27 Mil. Therefore, Intec Parent's EV-to-EBIT ratio for today is -1.24.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Intec Parent's Enterprise Value is $17.75 Mil.
Intec Parent's EBITDA for the trailing twelve months (TTM) ended in Mar. 2021 was $-12.85 Mil. Therefore, Intec Parent's EV-to-EBITDA ratio for today is -1.38.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Intec Parent's Enterprise Value is $17.75 Mil.
Intec Parent's Revenue for the trailing twelve months (TTM) ended in Mar. 2021 was $0.00 Mil. Therefore, Intec Parent's EV-to-Revenue ratio for today is .
Intec Parent Enterprise Value Historical Data
The historical data trend for Intec Parent's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Intec Parent's Enterprise Value
For the Biotechnology subindustry, Intec Parent's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Intec Parent's Enterprise Value Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Intec Parent's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Intec Parent's Enterprise Value falls into.
Intec Parent Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Intec Parent's Enterprise Value for the fiscal year that ended in Dec. 2020 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Intec Parent (NAS:NTEC) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Intec Parent's current Enterprise Value is $17.75 Mil.
Intec Parent's EBIT for the trailing twelve months (TTM) ended in Mar. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $-14.27 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Intec Parent's current Enterprise Value is $17.75 Mil.
Intec Parent's EBITDA for the trailing twelve months (TTM) ended in Mar. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $-12.85 Mil.
Intec Parent's current Enterprise Value is $17.75 Mil.
Intec Parent's Revenue for the trailing twelve months (TTM) ended in Mar. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Intec Parent Enterprise Value Related Terms
Thank you for viewing the detailed overview of Intec Parent's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Intec Parent Inc, formerly Intec Pharma Ltd is a clinical-stage biopharmaceutical company based in Israel. The company is focused on research and development and clinical trials. The company develops formulations of drugs using its proprietary gastric retention technology, the Accordion Pill. Accordion Pill is an oral drug delivery system that is designed to improve the efficacy and safety of existing drugs and drugs in development by utilizing efficient gastric retention. Accordion Pill Carbidopa/Levodopa or AP-CDLD is being developed by the company for the indication of treatment of Parkinson's disease.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NTEC has been successfully added to your 